MedPath

Comparison of two drugs (Epinephrine and Dopamine) for achieving hemodynamic stability (normal blood pressure and adequate cardiac output) in newborn babies with septic shock

Not Applicable
Completed
Conditions
Health Condition 1: null- Septic shock
Registration Number
CTRI/2015/10/006285
Lead Sponsor
PGIMERChandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
64
Inclusion Criteria

a.Shock diagnosed as hypotension ( <5th centile

according to Zubrowâ??s charts)48

b.Presence of fluid refractory shock. Fluid

refractory shock5,10,40 is defined as the

presence of signs of septic shock despite fluid

challenge (two boluses of 10 ml / kg each given

over 15-20 minutes each).

c.Peripheral circulatory dysfunction - Two of the

following

• Oliguria: urine output < 0.5 ml /kg / hr.

•Prolonged capillary refill: >4 sec.

•Core to peripheral temperature gap > 3ï?° C

(Term)

•Unexplained metabolic acidosis: base

deficit > 5.0 mEq / L.

•Increased arterial lactate > 2 times upper

limit of normal

Exclusion Criteria

1.Presence of lethal congenital malformations.

2.Hypovolemic shock- setting of blood loss (ante

partum hemorrhage, obvious blood loss, clinical

features of dehydration ie setting of fluid

loss and / or depressed anterior fontanel,

sunken eyeballs.

3.Baby diagnosed or suspected to have Duct

dependent congenital heart disease.

4.Suspected or proven Cardiogenic shock- setting

of Lt to Rt shunt with no evidence of sepsis

5.Shock in VLBW Babies in first 12 hrs of life,

who donâ??t have settings of sepsis.

6.Severe birth asphyxia with evidence of HIE II or

III in term / near-term neonates of 36 weeks

(Sarnat staging) or moderate / severe

encephalopathy (Levene classification) in

preterm neonates of < 36 weeks.

7.Shock in VLBW Babies in first 12 hrs of life,

who donâ??t have settings of sepsis

8.Baby already on vasopressors.

9.Study investigator to perform

echocardiography is not available

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i.The primary outcome variable will be reversal of signs of septic shock. The reversal of signs of septic shock will be defined as a composite outcome of all of the following: <br/ ><br>A.Systolic and diastolic blood pressure more than 5th centile in Zubrowâ??s chart. <br/ ><br>B.Capillary refill time of 3 sec independently assessed by two observers. <br/ ><br>C.Left ventricular output of â?¥150 mL/kg/min. <br/ ><br>Timepoint: 1 hr 30 in <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
<br/ ><br>1.Total time to achieve hemodynamic stability. <br/ ><br>2.Duration of all vasoactive drug use. <br/ ><br>3.Proportion of neonates requiring other vasoactive drugs <br/ ><br>4.Change in metabolic acidosis, lactate from baseline. <br/ ><br>5.All-cause mortality till 28 days of life <br/ ><br>6.Incidence of IVH, BPD, NEC, ROP <br/ ><br>7.Change in cardiac output, ejection fraction and Celiac / Middle cerebral artery blood flow from baseline.Timepoint: Not fixed
© Copyright 2025. All Rights Reserved by MedPath